No evidence of increased cancer incidence in children using topical tacrolimus for atopic dermatitis

Background - Long-term safety of topical calcineurin inhibitors is not well understood. APPLES (A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis; NCT00475605) examined incidence of lymphoma and other cancers...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Paller, Amy S. (VerfasserIn) , Fölster-Holst, Regina (VerfasserIn) , Chen, Suephy C. (VerfasserIn) , Diepgen, Thomas L. (VerfasserIn) , Elmets, Craig (VerfasserIn) , Margolis, David J. (VerfasserIn) , Pollock, Brad H. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 1 April 2020
In: Journal of the American Academy of Dermatology
Year: 2020, Jahrgang: 83, Heft: 2, Pages: 375-381
ISSN:1097-6787
DOI:10.1016/j.jaad.2020.03.075
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.jaad.2020.03.075
Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0190962220304989
Volltext
Verfasserangaben:Amy S. Paller, MD, Regina Fölster-Holst, MD, Suephy C. Chen, MD, MS, Thomas L. Diepgen, MD, PhD, Craig Elmets, MD, David J. Margolis, MD, PhD, and Brad H. Pollock, MPH, PhD

MARC

LEADER 00000caa a2200000 c 4500
001 1737441926
003 DE-627
005 20240407193415.0
007 cr uuu---uuuuu
008 201030s2020 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.jaad.2020.03.075  |2 doi 
035 |a (DE-627)1737441926 
035 |a (DE-599)KXP1737441926 
035 |a (OCoLC)1341375281 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Paller, Amy S.  |e VerfasserIn  |0 (DE-588)173804039  |0 (DE-627)698707680  |0 (DE-576)134643798  |4 aut 
245 1 0 |a No evidence of increased cancer incidence in children using topical tacrolimus for atopic dermatitis  |c Amy S. Paller, MD, Regina Fölster-Holst, MD, Suephy C. Chen, MD, MS, Thomas L. Diepgen, MD, PhD, Craig Elmets, MD, David J. Margolis, MD, PhD, and Brad H. Pollock, MPH, PhD 
264 1 |c 1 April 2020 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 30.10.2020 
520 |a Background - Long-term safety of topical calcineurin inhibitors is not well understood. APPLES (A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis; NCT00475605) examined incidence of lymphoma and other cancers in a pediatric population with atopic dermatitis. - Objective - To quantify incident malignancies during 10 years in children with atopic dermatitis who used topical tacrolimus for ≥6 weeks. - Methods - Standardized incidence ratios for cancer events were analyzed relative to sex-, age-, and race-matched control data from national cancer registries. - Results - There were 7954 eligible patients enrolled at 314 sites in 9 countries. During 44,629 person-years, 6 confirmed incident cancers occurred (standardized incidence ratio, 1.01; 95% confidence interval, 0.37-2.20). No lymphomas occurred. - Limitations - Observational prospective cohort study. - Conclusion - The cancer incidence was as expected, given matched background data. This finding provides no support for the hypothesis that topical tacrolimus increases long-term cancer risk in children with atopic dermatitis. 
650 4 |a atopic dermatitis 
650 4 |a cancer risk 
650 4 |a lymphoma 
650 4 |a skin cancer 
650 4 |a tacrolimus 
650 4 |a topical calcineurin inhibitors 
700 1 |a Fölster-Holst, Regina  |e VerfasserIn  |4 aut 
700 1 |a Chen, Suephy C.  |e VerfasserIn  |4 aut 
700 1 |a Diepgen, Thomas L.  |d 1953-2020  |e VerfasserIn  |0 (DE-588)120024136  |0 (DE-627)080392725  |0 (DE-576)166354066  |4 aut 
700 1 |a Elmets, Craig  |e VerfasserIn  |4 aut 
700 1 |a Margolis, David J.  |e VerfasserIn  |4 aut 
700 1 |a Pollock, Brad H.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |a American Academy of Dermatology  |t Journal of the American Academy of Dermatology  |d Amsterdam [u.a.] : Elsevier, 1979  |g 83(2020), 2, Seite 375-381  |h Online-Ressource  |w (DE-627)320411745  |w (DE-600)2001404-1  |w (DE-576)094426791  |x 1097-6787  |7 nnas 
773 1 8 |g volume:83  |g year:2020  |g number:2  |g pages:375-381  |g extent:7  |a No evidence of increased cancer incidence in children using topical tacrolimus for atopic dermatitis 
856 4 0 |u https://doi.org/10.1016/j.jaad.2020.03.075  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0190962220304989  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20201030 
993 |a Article 
994 |a 2020 
998 |g 120024136  |a Diepgen, Thomas L.  |m 120024136:Diepgen, Thomas L.  |d 910000  |d 911900  |e 910000PD120024136  |e 911900PD120024136  |k 0/910000/  |k 1/910000/911900/  |p 4 
999 |a KXP-PPN1737441926  |e 3789519235 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1737441926","language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 30.10.2020"],"title":[{"title_sort":"No evidence of increased cancer incidence in children using topical tacrolimus for atopic dermatitis","title":"No evidence of increased cancer incidence in children using topical tacrolimus for atopic dermatitis"}],"person":[{"family":"Paller","given":"Amy S.","display":"Paller, Amy S.","roleDisplay":"VerfasserIn","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Fölster-Holst, Regina","role":"aut","family":"Fölster-Holst","given":"Regina"},{"given":"Suephy C.","family":"Chen","role":"aut","roleDisplay":"VerfasserIn","display":"Chen, Suephy C."},{"given":"Thomas L.","family":"Diepgen","role":"aut","display":"Diepgen, Thomas L.","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","display":"Elmets, Craig","role":"aut","family":"Elmets","given":"Craig"},{"role":"aut","display":"Margolis, David J.","roleDisplay":"VerfasserIn","given":"David J.","family":"Margolis"},{"given":"Brad H.","family":"Pollock","role":"aut","display":"Pollock, Brad H.","roleDisplay":"VerfasserIn"}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisher":"Elsevier ; Mosby","dateIssuedKey":"1979","dateIssuedDisp":"1979-","publisherPlace":"Amsterdam [u.a.] ; St. Louis, Mo."}],"id":{"issn":["1097-6787"],"zdb":["2001404-1"],"eki":["320411745"]},"disp":"American Academy of DermatologyJournal of the American Academy of Dermatology","note":["Gesehen am 19.02.20"],"type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"320411745","corporate":[{"role":"aut","display":"American Academy of Dermatology","roleDisplay":"VerfasserIn"}],"language":["eng"],"pubHistory":["1.1979 -"],"titleAlt":[{"title":"JAAD"}],"part":{"volume":"83","text":"83(2020), 2, Seite 375-381","extent":"7","year":"2020","issue":"2","pages":"375-381"},"title":[{"title_sort":"Journal of the American Academy of Dermatology","subtitle":"JAAD","title":"Journal of the American Academy of Dermatology"}]}],"physDesc":[{"extent":"7 S."}],"id":{"eki":["1737441926"],"doi":["10.1016/j.jaad.2020.03.075"]},"origin":[{"dateIssuedDisp":"1 April 2020","dateIssuedKey":"2020"}],"name":{"displayForm":["Amy S. Paller, MD, Regina Fölster-Holst, MD, Suephy C. Chen, MD, MS, Thomas L. Diepgen, MD, PhD, Craig Elmets, MD, David J. Margolis, MD, PhD, and Brad H. Pollock, MPH, PhD"]}} 
SRT |a PALLERAMYSNOEVIDENCE1202